BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 15910549)

  • 1. Metals and amyloid-beta in Alzheimer's disease.
    Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
    Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
    Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
    FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease.
    Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W
    Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper and Alzheimer's Disease.
    Mathys ZK; White AR
    Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels.
    Schäfer S; Pajonk FG; Multhaup G; Bayer TA
    J Mol Med (Berl); 2007 Apr; 85(4):405-13. PubMed ID: 17211610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron.
    Maynard CJ; Cappai R; Volitakis I; Cherny RA; White AR; Beyreuther K; Masters CL; Bush AI; Li QX
    J Biol Chem; 2002 Nov; 277(47):44670-6. PubMed ID: 12215434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of copper and the copper-related protein CUTA in mediating APP processing and Aβ generation.
    Hou P; Liu G; Zhao Y; Shi Z; Zheng Q; Bu G; Xu H; Zhang YW
    Neurobiol Aging; 2015 Mar; 36(3):1310-5. PubMed ID: 25557959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis.
    Zhang J; Liu Q; Chen Q; Liu NQ; Li FL; Lu ZB; Qin C; Zhu H; Huang YY; He W; Zhao BL
    FASEB J; 2006 Jun; 20(8):1212-4. PubMed ID: 16627626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
    Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
    J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
    Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
    Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is interaction of amyloid β-peptides with metals involved in cognitive activity?
    Tamano H; Takeda A
    Metallomics; 2015 Aug; 7(8):1205-12. PubMed ID: 25959547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology.
    Maynard CJ; Cappai R; Volitakis I; Cherny RA; Masters CL; Li QX; Bush AI
    J Inorg Biochem; 2006 May; 100(5-6):952-62. PubMed ID: 16574231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease.
    Bayer TA; Schäfer S; Breyhan H; Wirths O; Treiber C; Multhaup G
    Clin Neuropathol; 2006; 25(4):163-71. PubMed ID: 16866297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metallobiology of Alzheimer's disease.
    Bush AI
    Trends Neurosci; 2003 Apr; 26(4):207-14. PubMed ID: 12689772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.